 |
市場調査レポート
イソフラボンの世界市場 - 2025年までの予測：医薬品・機能性食品・化粧品・飲食品向けIsoflavones Market by Source (Soy, Red Clover), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), Form (Powder and Liquid), and Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2025 |
||||||
| 発行 | MarketsandMarkets | 商品コード | 915969 | ||||
| 出版日 | ページ情報 | 英文 130 Pages  |
|||||
| 価格 |
|
||||||
| イソフラボンの世界市場 - 2025年までの予測：医薬品・機能性食品・化粧品・飲食品向け Isoflavones Market by Source (Soy, Red Clover), Application (Pharmaceuticals, Nutraceuticals, Cosmetics, and Food & Beverages), Form (Powder and Liquid), and Region (North America, Europe, Asia Pacific, RoW) - Global Forecast to 2025 | ||
| 出版日: 2019年11月05日 | ページ情報: 英文 130 Pages |
|
世界のイソフラボン市場は、2019年の11億米ドルから、2025年までに15億米ドルまで拡大すると見られています。市場は、2019年～2025年のCAGR (複合年間成長率) で、4.7％の成長が予測されています。
当レポートでは、世界のイソフラボン市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。
The global isoflavones market is estimated to be valued at USD 1.1 billion in 2019 and is likely to reach USD 1.5 billion by 2025, growing at a CAGR of 4.7% during the forecast period. Isoflavones are a phytoestrogen produced mainly by plants of the legume family, namely, soybeans, chickpeas, and red clover. They are potentially useful in lowering cholesterol, treating cancers and menopausal symptoms, maintain bone health, and so on. Growth in this market is mainly driven by the increasing incidences of chronic diseases, rising prevalence of cancer, technological advancements in the manufacturing of isoflavones, and the rapidly increasing geriatric population. However, stringent regulatory requirements and unfavorable drug price control policies across various countries are significant factors that are expected to restrain the growth of this market to a certain extent.
Based on the source, the soy segment is estimated to account for the largest share in the isoflavones market in 2019. The segment is growing owing to factors such as nutritional and functional health-related properties since soy isoflavones are derived from soybeans and are particularly prevalent in soy germ. Genistein and daidzein are the major isoflavones present in soybean, which help in promoting overall health and wellness.
Based on the application, pharmaceuticals are estimated to account for the largest market share. The factors behind the growth is increasing the prevalence of diseases such as cancer, osteoporosis, and arthritis fuels the demand for isoflavones as they reduce the risk of the above-mentioned diseases and provide therapeutic effects.
The North America region is projected to hold the major market share in the isoflavones market. It includes the US, Canada, Mexico. According to the United States Department of Agriculture, the US produced 341.62 million metric tons of soybean, Canada produced 7.72 million metric tons, and Mexico 0.43 million metric tons, in the year 2017-2018. The region is one of the leading producers of soybeans, which creates ample opportunities for the manufacturing of isoflavones. Another factor propelling the growth of isoflavones in the region is rising obesity, which is a major concern among the youth, which is directing consumer focus toward a healthy lifestyle, thereby promoting their overall health and wellness.
Others include: sales managers, marketing managers, and product managers.
*RoW includes South America and the Middle East & Africa.
This report includes a study of marketing and development strategies along with the product portfolios of the leading companies in the isoflavones market. It consists of the profiles of leading companies such as Cargill (Germany), ADM (US), BASF (Germany), DSM (Netherlands), International Flavors and Fragrances (Frutarom) (US), Shanghai Freemen (US), Nexira Inc. (France), Bio-gen Extracts, Sikko Industries, SK Bioland (South Korea), BioMax (India), Avestia Pharma (India), NutraScience Labs (US), Tradichem S.L. (Spain), Nutra Green Biotechnology (China), Herbo Nutra (India), FutureCeuticals Inc. (US), Bio-gen Extracts (US), Xena Bio Herbals Pvt. Ltd. (India), Sikko Industries (India), Biomax (India), and Lactonova (India).
The report segments the isoflavones market based on source, application, form, and region. In terms of insights, this report has focused on various levels of analyses-competitive landscape, end-use analysis, and company profiles-which together comprise and discuss views on the emerging & high-growth segments of the global isoflavones high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
(Business overview, Products offered, Recent developments & SWOT analysis)*
Details on Business overview, Products offered, Recent developments & SWOT analysis might not be captured in case of unlisted companies.
